1. Home
  2. CERS vs NPCE Comparison

CERS vs NPCE Comparison

Compare CERS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.64

Market Cap

501.8M

Sector

Technology

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$14.34

Market Cap

490.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CERS
NPCE
Founded
1991
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
501.8M
490.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CERS
NPCE
Price
$2.64
$14.34
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
1.3M
109.0K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
29.03
EPS
N/A
N/A
Revenue
$51,326,000.00
$99,986,000.00
Revenue This Year
$19.95
$0.90
Revenue Next Year
$8.84
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
30.68
25.13
52 Week Low
$1.38
$9.22
52 Week High
$3.47
$19.60

Technical Indicators

Market Signals
Indicator
CERS
NPCE
Relative Strength Index (RSI) 51.36 49.93
Support Level $2.37 $13.76
Resistance Level $2.68 $14.72
Average True Range (ATR) 0.09 0.51
MACD 0.01 -0.00
Stochastic Oscillator 81.25 38.22

Price Performance

Historical Comparison
CERS
NPCE

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: